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In 2018, 3 million new cases of cancer (all types, excluding non-melanoma skin cancer) and over 
1.4 million cancer-related deaths are estimated in EU-28. Population-based cancer registries 
represent the invaluable data source for providing unbiased information on cancer burden in a 
defined population over a certain calendar period. They are critical resources for the clinical and 
epidemiological investigation of cancer and for the planning and evaluation of cancer prevention 
and control programmes. 
The European Cancer Information System, officially released in February 2018, disseminates cancer 
burden indicators at European level, namely on incidence, mortality and survival, derived from data 
submitted by about 150 European population-based cancer registries. It provides an added value 
by allowing regional/national comparison of cancer indicators and prompting key questions on the 
aetiology of certain types of cancer and on the comparison of best practices in prevention, diagnosis 
and treatment interventions.
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Preface
3
The current political and economic challenges faced by the European Union and its Member States call even 
more for evidence-informed policies. They also require tailor-made policies, developed using highly sophis-
ticated analyses based not only on country-level data, but rather on regional and sub-regional knowledge. 
National averages, in particular, bear the risk to present a misleading picture in countries with significant 
disparities between different regions and areas. 
Looking only at national averages can also limit and delay understanding of the differences between 
regions and cities – identifying leaders and laggards –, as well as prevent the identification of emerging 
trends in certain socio-economic indicators. Only a detailed analysis of data at regional and local level can 
bring these insights.
The Joint Research Centre (JRC) of the European Commission has developed the Socio-economic regional 
microscope. It is a new series of short periodical publications which aims to open-up new areas of analysis, 
and present the stories which can only be told using regional socio-economic data.
Each report presents EU socio-economic indicators according to a data storytelling principle, using a 
combination of three key elements: data, visuals (maps), and narrative. Each indicator will therefore be 
represented through maps at regional level (NUTS2), and in some cases even at the NUTS3 and local level.
The Socio-economic regional microscope will also show the breadth of the JRC regional analysis in a 
wide range of research areas: culture, economics, education, energy, healthcare, research and innovation, 
tourism, etc.
The reports, data and maps are also available on the Territorial Dashboard website of the JRC Knowledge 
Centre for Territorial Policies, in the Thematic Analyses section: http://urban.jrc.ec.europa.eu/t-board/indic.html.
The Socio-economic regional 
microscope series
Socio-economic regional microscope series
1 ECIS – European Cancer Information System was released early 2018 by the European Commissions’ Joint Research Centre (JRC) 
to promote awareness on cancer burden, monitor its magnitude and follow trends and changes over time, https://ecis.jrc.ec.europa.eu
2 EUROSTAT – Causes of death statistics, http://ec.europa.eu/eurostat/statistics-explained/index.php?title=Causes_of_death_statistics
3 IARC Technical publications No.43, https://www.iarc.fr/en/publications/pdfs-online/treport-pub/treport-pub43/IARC_Technical_ 
Report_No43.pdf
4 Since 2012, the JRC in close collaboration with the Directorate-General for Health and Food Safety (DG SANTE), is ensuring 
continued administrative functioning of the ENCR network, and is supporting further coordination and harmonisation of European 
Cancer data.
5 The ENCR includes registries operating in countries within the UN geographical definition of Europe: http://unstats.un.org/unsd/
methods/m49/m49regin.htm#europe
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Introduction
With more than 3 million new cases and 1.4 million deaths estimated for 20181, cancer represents the 
second most important cause of death and morbidity in the EU-28, after circulatory diseases2.
Population-based cancer registration represents the ‘gold’ standard for the provision of unbiased information 
on cancer burden in a defined population and how it is changing over time3. 
Population-based cancer registries (PBCRs) collect, manage and analyse data on patients diagnosed with 
cancer within a defined geographical area over a certain calendar period. They are invaluable resources for 
the clinical and epidemiological investigation of cancer and have a unique role in supporting public health 
officials and agencies in the planning and evaluation of cancer prevention and control programmes. 
The European Network of Cancer Registries (ENCR)4, in operation since 1990, was established within the 
framework of the Europe Against Cancer Programme of the European Commission. The ENCR promotes 
collaboration between cancer registries, defines data collection standards, and supports cancer registries 
as data providers for the supply of information necessary to quantify and monitor the burden of cancer in 
the European Union and Europe5.
The first ‘modern’ PBCR was established in Hamburg, Germany already in 1926. In the next decades, 
European cancer registration expanded its coverage, particularly after World War II. Today, there are ap-
proximately 200 active cancer registries (CRs) in Europe, with around 80 % of the population covered in 
the EU-28 plus the EFTA countries Norway, Switzerland and Iceland, according to the records of the ENCR, 
but a few European countries still show sparse geographical cancer registration (Figure 1). 
European PBCRs are heterogeneous entities in terms of their organization, funding, and size. Some may 
cover just a metropolitan area or a province while others may be nation-wide organizations. They may 
record all cancers (all cancer sites and all ages) or be specialized in a certain cancer site or age group.
In June 2015, the ENCR and the European Commission’s Directorate General Joint Research Centre (JRC) 
launched a Call for Data addressed to all European PBCRs, with the aim of establishing a single European 
cancer-registry data repository for use by any European wide study on cancer incidence, mortality, survival 
and prevalence.
Historical data collected by PBCRs enable to uncover possible significant improvements in the fight against 
specific cancers that can be due to different types of interventions, either resulting from a reduced exposure 
to major risk factors, earlier diagnosis through the implementation of screening programs and/or better 
treatment schemes.
Examples are given below for some of the leading cancer sites for women and men in Europe, whose trends 
and geographical distribution are analysed for the EU-28 / EFTA countries in the context of different types 
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of interventions, as mentioned above. These include the i) analysis of changing trends in incidence and 
mortality for breast cancer in women in light of several targeted interventions factors, such as the im-
plementation of breast cancer screening programs across the EU, ii) analysis of lung cancer trends across 
Europe considering the changes in smoking prevalence (a major risk factor) by gender and geographic 
distribution, and iii) analysis of stomach cancer trends in incidence and mortality following improvements 
in primary prevention over the last decades. All cancer indicators are given as population-based rates (per 
100,000 people), age-standardised using the new European standard population6.
The figures reported in the current publication consist of indicators computed from observed data (reported 
in the trend analysis) and estimates for incidence and mortality indicators for 2018.  
It has to be noted that the variations in estimated indicators across European countries is influenced by a 
number of factors, including different levels of primary prevention and care, population-based screening, 
data registration coverage as well as the methods used for estimation. Thus the interpretation of the 
figures reported in this publication needs to take these factors into consideration.
Geographical coverage
% population coverage
Figure 1. Timeline increase  
in cancer registration for all ages 
and all cancer sites in the EU-28/ 
EFTA countries. 
Inset: Pie chart showing the 
increase in population covered  
by cancer registrations in  
the last decades.
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Figure 2a. Estimated age-standardised rates (according to the European new standard population), per 100,000 people, for female breast cancer incidence (left) 
and mortality (right) for 2018. The countries are colored within a range from the minimum to the maximum estimated rates.
Breast cancer is the leading cancer site for incidence and the main cause of cancer death among women in 
Europe, according to estimates for 2018 (Figure 2). Known risk factors for breast cancer in women include: 
age, exposure to oestrogen, genetic predisposition, some breast conditions and lifestyle-related factors7.
Monitoring the breast cancer 
burden in Europe
7 ENCR Breast cancer Factsheet (2014), https://encr.eu/sites/default/files/factsheets/ENCR_Factsheet_Breast_2014.pdf
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Figure 2b. Comparison of female incidence and mortality estimates for breast cancer by country and EU-28. Source: ECIS1.
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The incidence of breast cancer varies widely across the EU-28 / EFTA countries, however there has been 
an overall rising trend in most countries1. On the contrary, breast cancer mortality rates have fallen in many 
countries since the mid-1990s (Figure 3).
Time trends Mortality, breast cancer, females
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Several factors could be responsible for the observed trends in breast cancer incidence and mortality, but 
a rise in risk factors and changes in early diagnostic factors and treatment are likely contributors.
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Figure 2. Total prevalence of Down syndrome in 10.000 total births by six maternal age groups (based on EUROCAT data 1990-2014).
Time trends Incidence, breast cancer, females
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Mammographic screening has been widely accepted as a main tool for early detection of breast cancer. 
Population coverage by breast cancer screening programmes has increased in the last decades (Table 1) and 
different levels of maturation of the screening programmes exist currently across the EU-28, ranging from 
3 to 20 years from implementation (Figure 4). The Council Recommendations of 2003 on cancer screening 
recommends that Member States implement mammographic screening programs in women aged 50-698. 
However, it is up to each Member State to extend or shorten the screening age, depending on national pol-
icies (Table 1). Currently, the European Initiative on Breast Cancer9 (ECIBC) is developing evidence-based 
recommendations for mammographic screening which aim to harmonise the practice in the EU. 
8 COUNCIL RECOMMENDATION of 2 December 2003 on cancer screening (2003/878/EC)
9 ECIBC: http://ecibc.jrc.ec.europa.eu
10 IARC (2017) Cancer Screening in the EU. Report on the implementation of the Council Recommendation on cancer screening.
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Member States
Breast cancer screening programme in the EU
Year of programme initiation Target age (years)
Austria 2014 45-69
Belgium 2001* 50-69
Bulgaria NA 50-69
Croatia 2006 50-69
Cyprus 2003 50-69
Czech Republic 2002 45+
Denmark 2008 50-69
Estonia 2003 50-64
Finland 1987 50-69
France 2004 50-74
Germany 2005 50-69
Greece NA 40+
Hungary 2001 45-64
Ireland 2000 50-69
Italy 1990 45-74*
Latvia 2009 50-69
Lithuania 2005 50-69
Luxembourg 1992 50-69
Malta 2009 50-69
Netherlands 1989 50-75
Poland 2006 50-69
Portugal 1990 45-74*
Romania 2015 50-69
Slovakia NA -
Slovenia 2008 50-69
Spain 1990 50-69*
Sweden 1986 40-74
United Kingdom 1988* 50-70
Table 1. Breast cancer screening programmes in the EU, year of programme initiation and target age. Modified from IARC (2017)10. 
* countries with regional differences in the date of implementation or the target age group
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Continuous surveillance carried out by cancer registries is an important tool for monitoring the evolution of the 
breast cancer epidemic in Europe. Indeed, PBCRs data may be exploited for measuring the impact of control 
measures such as screening programs for breast cancer on the incidence, mortality and survival indicators. 
1110
Figure 4. Breast cancer screening programmes in the EU. Status of implementation of breast cancer screening programmes. Modified from IARC (2017)10.
Rollout complete PilotingRollout ongoing Non-population-based programme
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Lung cancer is estimated as the third most frequent cancer in the EU-28/ EFTA countries for 2018, and the 
most common cause of cancer death in men and women (Figure 5). Smoking, especially cigarettes, is the 
main risk factor, accounting for more than 80% of the total number of lung cancers11, 12, 13.
Monitoring lung cancer burden  
at national and sub-national level
11 Horn L, et all editors (2012) Principles of Internal Medicine. McGraw-Hill.
12 Biesalski et al (1998) CA Cancer J Clin, 48(3), 167-76.
13 ENCR Lung cancer factsheet (2014), https://encr.eu/sites/default/files/factsheets/ENCR_Factsheet_Lung_2014.pdf.
Figure 5a. Estimated age-standardised rates (according to the European new standard population), per 100,000 people, for lung cancer incidence (left) and 
mortality (right) for both sexes, for 2018. The countries are colored within a range from the minimum to the maximum estimated rates.
Incidence, lung cancer, both sexes Mortality, lung cancer, both sexes
Age standardised rate x 100,000
40.0 - 54.4 68.8 - 83.354.4 - 68.8
83.3 - 97.7 97.7 - 112.1
Age standardised rate x 100,000
38.2 - 48.8 59.3 - 69.948.8 - 59.3
69.9 - 80.4 80.4 - 91.0
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Figure 5b. Comparison of lung cancer incidence and mortality estimates by country and EU-28. Source: ECIS1.
Incidence and mortality, lung cancer, both sexes
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Interestingly, the characteristics of lung cancer incidence trends in Europe differ by gender (Figure 6). While 
the incidence in men has been decreasing in most European countries during the last two decades, the 
patterns in women have seen an increase, particularly in the West and Northern Europe, reflecting the 
difference in the smoking habits, which for women started later than for men.
Time trends Mortality, lung cancer, male
Austria DenmarkCzech Republic
Netherlands Poland
Estonia
Slovakia United Kingdom, England
Figure 6. Time trends of age-standardised rates (according to the European new standard population), per 100,000 people, for incidence of lung cancer in 
females (upper panel) and males (lower panel) from selected PBCRs. The entire period available is displayed. Source: ECIS1
Time trends Incidence, lung cancer, females
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National differences in lung cancer incidence and mortality usually reflect the level of the smoking epidemic 
in the different EU countries (Figure 7).
< 20 cigarettes per day ≥ 20 cigarettes per day * Data with low reliability
Figure 7. Proportion of daily smokers of cigarettes for population aged 15 years and over by level of consumption in the EU-28 countries, 201414.
Proportion of daily smokers of cigarettes in the EU-28, 2014
14 EUROSTAT - Tobacco consumption statistics: http://ec.europa.eu/eurostat/statistics-explained/index.php/Tobacco_consumption_ 
statistics
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The analysis of cancer incidence rates and risk factors pooled at national level, however, tend to dilute 
regional variability. As an example, Portugal is one of the EU-28 countries with the lowest estimated in-
cidence and mortality rates for lung cancer (Figure 5). However, when data are analysed at regional level, 
a considerable geographical heterogeneity is apparent, with the population in the Azorean archipelago 
presenting a significantly higher risk of developing some malignant diseases including lung cancer than the 
mainland Portuguese population15. Some major risk factors in the Azorean population, including tobacco 
smoking in men, have been suggested to account for geographical discrepancies, and interestingly the lung 
cancer incidence pattern (Figure 8) follows the regional differences in smoking prevalence (Figure 9), with 
a higher proportion of smokers identified in the Azores16.
PT, North Region PT, South RegionPT, Central Region PT, Azores
Figure 8. Time trends of age-standardised rates (according to the European new standard population) per 100,000 people for incidence of lung cancer in 
different regions in Portugal. The entire period available is displayed. Source: ECIS1
Time trends Incidence, lung cancer, males, Portugal
15 Lacerda GF, Pinheiro PS, Cabral JM Camara JG, Rodrigues VL (2012) Rev. Bras. Epidemiol. vol.15 no.2, http://dx.doi.org/10.1590/
S1415-790X2012000200006 
16 Statistics Portugal. Regional Statistical Yearbooks - Regional and municipal statistical data – 2015, https://www.ine.pt/xportal/
xmain?xpid=INE&xpgid=ine_destaques&DESTAQUESdest_boui=250508919&DESTAQUESmodo=2
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Figure 9. Proportion of the population aged 15 years and over that smokes every day, Portugal and NUTS 2 regions, 201417.
Similar situations of regional heterogeneity can be observed in other countries and for other cancer sites, 
indicating that country-level information may not be sufficient to depict exhaustively cancer trends and 
drive health policies.
Higher geographical detail allows greater resolution in identifying populations at risk, which otherwise would 
be overlooked if important indicators on cancer and risk factors exposure were averaged at national level.
Azores
Madeira
Daily smokers in Portugal
23,30015,000
 National proportion daily smokers 16.8
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Incidence and mortality rates of stomach cancer vary widely across Europe, with the highest rates 
observed in Eastern Europe (Figure 10). 
Monitoring stomach  
cancer burden
Figure 10a. Estimated age-standardised rates (according to the European new standard population), per 100,000 people, for stomach cancer incidence (left) and 
mortality (right) for both sexes, for 2018. The countries are colored within a range from the minimum to the maximum estimated rates.
Incidence, stomach cancer, both sexes Mortality, stomach cancer, both sexes
Age standardised rate x 100,000
7.7 - 12.1 16.4 - 20.812.1 - 16.4
20.8 - 25.1 25.1 - 29.5
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Recent estimates predict that around 80,000 new cases of stomach cancer will be diagnosed in 2018 in the 
EU-28/EFTA countries, placing stomach cancer as the 13th most commonly diagnosed cancer and the 7th most 
frequent cause of cancer deaths, in both sexes1. This contrasts with the last 2012 estimates when stomach 
cancer was placed as the 7th most diagnosed cancer and the 5th most frequent cause of cancer death.
18
Figure 10b. Comparison of lung cancer incidence and mortality estimates by country and EU-28. Source: ECIS1.
Incidence and mortality, stoamch cancer, both sexes
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A remarkable decline in the incidence rates of stomach cancer has been recorded by PBCRs in almost all countries, which is reflected 
in a similar decline in mortality (Figure 11).
Reasons for this decrease are probably due to improve¬ments in dietary patterns and standards of living and control of Helicobacter 
pylori infection.
1918
Austria
Time trends Mortality, stomach cancer, both sexes
DenmarkGermany, Saarland
Italy Lithuania
Spain
Netherlands Poland
Figure 11. Time trends of age-standardised rates (according to the European new standard population), per 100,000 people, for incidence (Left) and mortal-
ity (Right) of stomach cancer in both sexes reported by several European PBCRs. Source: ECIS1.
Time trends Incidence, stomach cancer, both sexes
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The Communication from the Commission to the European Parliament, the Council, the European Economic 
and Social Committee and the Committee of the Regions on Action Against Cancer; European Partnership 
(COM/2009/0291)3 acknowledges that: 
‘European comparisons have brought to light considerable differences in cancer survival in the EU between 
countries with similar levels of wealth and health care provision. As a result, a number of Member States, 
which reported relatively high cancer mortality in the early 1990s have reviewed and subsequently reformed 
their national cancer policies, and are today reporting improved cancer survival. By developing a European 
benchmark for best practice, there is in other words considerable scope for addressing health inequalities. 
Thus, sharing relevant information for statistical purposes is essential for developing effective public health 
interventions and the European benchmarking process.’
Population-based cancer registries undertake a crucial task on a daily basis of recording new cancer cases 
or updating existing ones with new clinical information, to build comprehensive data repositories that can 
inform regional or national health authorities on important cancer indicators such as incidence, prevalence, 
survival and mortality. The European Cancer Information System provides an added value of levering cancer 
indicators at European level. Regions in different countries sharing similar socio-economic characteristics 
may be identified and cancer indicators compared, thus prompting key questions on the aetiology of certain 
types of cancer or allowing comparison of best practices in prevention, diagnosis or treatment interventions.
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